Detalles de la búsqueda
1.
Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-I).
Lancet
; 401(10381): 1001-1010, 2023 03 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-36848918
2.
Baricitinib further enhances disease-modifying effects by uncoupling the link between disease activity and joint structural progression in patients with rheumatoid arthritis.
Ann Rheum Dis
; 81(5): 622-631, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35193872
3.
Mechanism of action of baricitinib and identification of biomarkers and key immune pathways in patients with active systemic lupus erythematosus.
Ann Rheum Dis
; 2022 May 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-35609978
4.
Quality of life in patients with breakthrough cancer pain in radiation oncology departments in Spain: the CAVIDIOR study.
Future Oncol
; 17(8): 943-954, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33289432
5.
Multicentre, randomised, open-label, parallel-group study evaluating the efficacy and safety of ixekizumab versus adalimumab in patients with psoriatic arthritis naïve to biological disease-modifying antirheumatic drug: final results by week 52.
Ann Rheum Dis
; 79(10): 1310-1319, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32660977
6.
Dose reduction of baricitinib in patients with rheumatoid arthritis achieving sustained disease control: results of a prospective study.
Ann Rheum Dis
; 78(2): 171-178, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30194275
7.
The effect of JAK1/JAK2 inhibition in rheumatoid arthritis: efficacy and safety of baricitinib.
Clin Exp Rheumatol
; 37(4): 694-704, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30767864
8.
Call for action: how to improve use of patient-reported outcomes to guide clinical decision making in rheumatoid arthritis.
Rheumatol Int
; 38(6): 935-947, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29564549
9.
Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study.
Ann Rheum Dis
; 76(1): 88-95, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-27689735
10.
Ultrasound-detected activity in rheumatoid arthritis on methotrexate therapy: Which joints and tendons should be assessed to predict unstable remission?
Rheumatol Int
; 36(3): 387-96, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26712373
11.
Predictive value of Doppler ultrasound-detected synovitis in relation to failed tapering of biologic therapy in patients with rheumatoid arthritis.
Rheumatology (Oxford)
; 54(8): 1408-14, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25731769
12.
Agreement in assessment of infliximab and adalimumab levels in rheumatoid arthritis: interlaboratory and interassay comparison.
Clin Exp Rheumatol
; 33(5): 617-23, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26316061
13.
Comparison of two ELISA versions for infliximab serum levels in patients diagnosed with ankylosing spondylitis.
Rheumatol Int
; 35(6): 1021-5, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25410014
14.
Efficacy and safety data based on historical or pre-existing conditions at baseline for patients with active rheumatoid arthritis who were treated with baricitinib.
Ann Rheum Dis
; 78(8): 1135-1138, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30842122
15.
Clinical relevance of monitoring serum levels of adalimumab in patients with rheumatoid arthritis in daily practice.
Clin Exp Rheumatol
; 32(6): 942-8, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25327159
16.
Young male patient diagnosed with cutaneous polyarteritis nodosa successfully treated with etanercept.
Mod Rheumatol
; 24(4): 688-9, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24981320
17.
Patient self-assessment and physician's assessment of rheumatoid arthritis activity: which is more realistic in remission status? A comparison with ultrasonography.
Rheumatology (Oxford)
; 52(12): 2243-50, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24046468
18.
Young male patient diagnosed with cutaneous polyarteritis nodosa successfully treated with etanercept.
Mod Rheumatol
; 2013 Jan 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-23359007
19.
A JAK Inhibitor for Treatment of Rheumatoid Arthritis: The Baricitinib Experience.
J Clin Med
; 12(13)2023 Jul 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37445562
20.
Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications.
Adv Ther
; 40(4): 1867-1883, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36802049